Physician

Dejuania Angela Brown-Rawls, D.O.

According to 2025 Medicare claims, Dejuania Brown-Rawls, D.O. (NPI: 1730379132) practices hematology/oncology in the Myrtle Beach-Conway-North Myrtle Beach, SC market, with the plurality of this provider's patient population coming from Horry, SC. This provider's primary affiliated billing organization is COASTAL CANCER CENTER LLC (NPI: 1881614170; TIN: 570777346) and primary practice location at 29572-4128.

Brown-Rawls' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,003 traditional Medicare patients, billed 210,282 HCPCS/CPT codes, and received $3,866,332 in Medicare payments. The top billing code was 36415 (Insertion of needle into vein for collection of blood sample). Part D data shows 1,091 prescription claims across 224 beneficiaries totaling $3,479,409 in drug costs, led by Lenalidomide (Lenalidomide). DME data shows 47 claims. Open Payments data shows 40 records totaling $1,375. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $109,886 to $3,866,332. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $666,056 to $3,479,409. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	403	1,681	$109,886
2016	430	1,536	$106,415
2017	978	271,653	$1,735,955
2018	1,020	253,459	$1,890,824
2019	926	237,426	$1,843,749
2020	983	269,819	$2,579,407
2021	1,298	355,471	$3,318,372
2022	1,442	293,672	$4,024,354
2023	1,559	320,412	$4,632,346
2024	1,003	210,282	$3,866,332

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	221	1,185	$666,056
2016	229	1,081	$639,502
2017	154	421	$286,652
2018	124	428	$796,624
2019	155	716	$1,441,150
2020	189	999	$2,429,440
2021	228	1,019	$3,011,353
2022	211	1,003	$2,980,445
2023	238	976	$3,604,159
2024	224	1,091	$3,479,409

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	22	$25,257
2016	N/R	11	$163
2017	N/R	N/R	N/R
2018	N/R	11	$1,087
2019	N/R	N/R	N/R
2020	N/R	17	$1,646
2021	N/R	83	$4,790
2022	N/R	106	$3,267
2023	N/R	26	$1,108
2024	N/R	47	$1,233

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
36415	Insertion of needle into vein for collection of blood sample	731	2,644	$9
80076	Liver function blood test panel	666	1,819	$8
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	722	2,632	$8
83615	Lactate dehydrogenase (enzyme) level	666	1,814	$6
82565	Blood creatinine level	666	1,832	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	59	1,526	$737,370
Ibrance	Palbociclib	27	756	$419,472
Imbruvica	Ibrutinib	25	700	$399,148
Verzenio	Abemaciclib	20	560	$290,630
Thalomid	Thalidomide	14	392	$221,610

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	19	$706
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	17	$320
K0001	Standard wheelchair	Y	N/R	11	$207

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	40	$1,375	Adaptive Biotechnologies Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Dejuania Angela Brown-Rawls, D.O.?

Tedicare shows public-source Medicare data for Dejuania Angela Brown-Rawls, D.O. (NPI 1730379132), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Dejuania Angela Brown-Rawls, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Dejuania Angela Brown-Rawls, D.O.?

Dejuania Angela Brown-Rawls, D.O. is linked to COASTAL CANCER CENTER LLC (billing NPI 1881614170) in the available physician profile data.

Does Dejuania Angela Brown-Rawls, D.O. have Open Payments data?

Dejuania Angela Brown-Rawls, D.O. has 40 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.